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Introduction 
The usage of laser in medicine is not recent, and the 
history of its use in urology goes back to 40 years ago. The 
first scientist who propounded the theory of ‘stimulated 
emission’ in 1917 was Albert Einstein, “the process by 
which photons with a certain amount of energy could 
disturb an excited atom and make it to drop to a lower 
energy level, after that, creation of another identical 
photon occurs. The original photon which interacts with 
the atom, as well as the photon which will be subsequently 
released, will be simultaneously discharged and will have 
an identical wavelength and direction of propagation.”1
Development of the “microwave amplification by 
stimulated emission of radiation” (MASER) was the first 
significant leap. Microwaves referred to as electromagnetic 
waves with fairly long wavelengths (1 mm-1 m). It was in 
1954, the first MASER was demonstrated in an oscillator 
by stimulated emission at microwave wavelengths.2 it took 
3 years from MASER to “light amplification by stimulated 
emission of radiation” (LASER).3
In 1960 Theodore Maiman succeeded to build the 
first LASER by using ruby crystals as active medium 
(chromium in corundum). The active medium in a laser 
defines the wavelength and frequency of the light which 
the laser emits and there is a reverse relationship between 
the wavelength and frequency.4
Gas was used as the active medium in the first lasers: 
carbon dioxide (CO2), nitrogen (N), neon (Ne) and 
helium (He). ‘Dye lasers’ use liquids as active media, 
because the nature of the lasing agent is an organic dye.5 
One of the advantages of dye lasers is the capability of 
generating amplified light which has a wider range of 
wavelengths. In 1964, one of the first solid-medium lasers 
was “neodymium-doped yttrium aluminium garnet” 
(Nd:YAG).6
One of the classifications of laser output in urology 
is continuous wave (CW); the output of the laser is 
continuously pumped and constantly emits light; whereas 
in pulsed wave (PW); it releases its energy in very short 
pulses which can have incredibly high peak powers, that 
is useful for stone fragmentation.7
The pioneers of lasers in clinical urology were Parsons 
with a research in canine bladders in 1966, Staehler et al 
in bladder tumors in 1976 and Mulvany with experiments 
in calculi fragmentation in 1968.5,8 
For the last 2 decades, laser techniques have been widely 
used for management of pa tients with urolithiasis, bladder 
tumors, benign prostatic hyperplasia (BPH), urinary tract 
strictures or le sions of the external genitalia.
Today, lasers broadly used in urology include 
Ho:YAG (holmium:YAG), Nd:YAG, CO2, Thu:YAG 
(thulium:YAG), LBO (lithium triborate), KTP (potassium 
titanyl phosphate). Due to frequent complications, the 
use of some types of lasers was stopped.2,6,7
Here we review all of the Iranian publications about the 
application of laser in urology.
Methods
This study was designed to retrieve all the studies on laser 
application in urology in Iran regardless of publication 
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status or language, covering the years 1990–2017. 
Searches were carried out using Medline, Web of Science, 
EMBASE, Scopus, Google Scholar and Iranian databases 
consisting of SID, IranMedex and IranDoc (keywords: 
laser, Iran, urolithiasis, benign prostatic hyperplasia, 
bladder tumor, urethral stricture). Additionally, reference 
lists of identified articles deemed relevant to the review 
were also searched. 
Twenty-six articles were identified: 12 about urolithiasis, 
8 about BPH, 2 case reports, 1 paper on prostate cancer, 1 
on female urethral stricture, 1 review and 1 basic sciences 
study.
Benign Prostatic Hyperplasia 
For the last 2 decades laser techniques have been widely 
used for the treatment of pa tients with BPH. The laser is 
able to ablate prostate tissue with minimal bleeding and 
this trait attracted urologists to use this modality to treat 
BPH.9 However, transurethral resection of the prostate 
(TURP) is still considered to be the ‘gold standard’ for 
minimally invasive management of BPH.10
The Nd:YAG laser was the most studied. One of the first 
surgical techniques used for the treatment of BPH was 
‘visual laser ablation of the prostate’ (VLAP).11 Hofstetter 
and Alvarez in 1993 described the interstitial laser 
coagulation (ILC) method with the Nd:YAG laser for 
management of BPH.12 Green light laser, KTP laser, PVP or 
photoselective vaporization of the prostate and frequency-
doubled Nd:YAG laser all refer to the same modality.13 A 
combination of KTP laser (to incise the bladder neck) and 
Nd:YAG laser ( to vaporize the prostate) named ‘hybrid 
techniques’ would decrease the neodymium-doped 
yttrium aluminium garnet laser’s postoperative symptoms 
(such as irritation) and decrease time of indwelling 
catheter.14 The next step of prostate ablation was the 120 
W LBO laser. The goal of this system was to compensate 
for the ability of relatively gentle tissue ablation of the 
‘high-level’ 80 W KTP, which ultimates the time constant 
procedures in large prostate.15 The Thu:YAG laser first 
published in 2005, is the newest laser equipment use for 
BPH surgery.16 The latter armamentarium published with 
‘Thu:YAG vapo-enucleation’, and ThuLEP (thulium laser 
enucleation of the prostate) followed them.17 Two articles 
published by Mahboub Ahari et al and Malek comparing 
PVP with TURP, showed that PVP is a safe procedure and 
has less complications.18,19 The holmium laser enucleation 
of the prostate (HoLEP) is another type of laser for BPH 
surgery, a comparison of this modality with TURP was 
published in 2011.20
Safarinezhad demonstrated that 30 of each 100 000 
Iranian men have BPH symptoms. Laser techniques were 
used in these patients as well as other surgical methods 
such as TURP and prostatectomy.21
The first report of laser application on BPH refers to 
Razzaghi and colleagues, who designed a randomized 
clinical trial study on 87 subjects in 2007 that compared 
laser prostatectomy versus TURP. The results showed 
that laser prostatectomy can reduce time being bed 
ridden, duration of operation and amount of fluid used 
in comparison with TURP and all differences were 
statistically significant. Also there was a remarkable 
difference in maximum urinary flow changes in patients 
whom underwent laser prostatectomy compared with 
TURP.22
Razzaghi et al evaluated the outcome of KTP Laser on 
prostate adenomas on 40 patients in 2010. They reported 
that in pathologic samples, 0 to 2 mm of tissue destruction 
with the disappearance of nuclei of the cells, basophilia of 
the stroma, and damaged tissue (cutter like effect) were 
witnessed. Findings were compatible with burn effect. 
The authors concluded that KTP laser prostatectomy 
has lower risk of complications such as perforation of 
capsule and extra penetration of prostate tissue during 
the procedure.23
Razzaghi et al reported treatment of human prostates by 
diode laser in 70 patients with BPH in 2012. This study 
explained that 100 nm 980 W diode laser vaporization 
prostatectomy was achievable and appeared to be 
unharmful and efficient for the treatment of bladder 
outlet obstruction. During surgery by diode laser, no 
intraoperative complications, fluid absorption or blood 
loss occurred. Important improvements after surgery 
include increase in Qmax, reductions in international 
prostate scoring system, and decrease in post-void 
residual (PVR) urine and there was significant decrease 
in PSA level and prostate volume after PVP at time of 
follow-up.24
In a randomized clinical trial on 115 cases with BPH that 
was published by Razzaghi et al in 2014 comparing diode 
laser (980 nm) vaporization with TURP. Diode laser was 
suggested as a safe procedure in the treatment of BPH; 
but, at longer time of follow-up, the efficacy of diode 
laser vaporization was inferior to TURP. In comparison 
of the TURP and diode groups, Foley catheterization time 
and postoperative hospitalization in the diode group was 
lower than for TURP (P = 0.0001). In the TURP group, 
capsule perforation, need for blood transfusion, and TUR 
syndrome were seen, whereas these complications were 
not observed in the other group.25
In a study in 2013, Iman Talab et al26 reported the 
management of anesthesia in a 69 years old patient with 
bladder rupture during prostate resection with laser 
diode 980 nm. Advised anesthesiologic approaches in 
the literature for such situations are (1) early diagnosis of 
bladder rupture, (2) spinal anesthesia instead of general 
anesthesia, (3) stop the surgery, (4) stop N2O halation 
in general anesthesia, and (5) execution of academic 
principles of surgical technique. 
Laser advantages include reduced risk of bleeding, 
possibility to use saline for washing, reduced absorption 
of fluids and reduced inflammation, the possibility of 
general anesthesia and sedation for most patients as well 
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as the ability to continue taking anticoagulant in patients 
at risk of thromboembolic complications.26
Treatment of Urolithiasis With Laser 
Renal stones treatment shifted from open surgery to less 
invasive interventions over the last decades.  Endoscopic 
laser lithotripsy is commonly used as a treatment for 
patients with urolithiasis. The first paper about pulsed dye 
laser for treatment of urolithiasis was presented in 1987.27 
The next one was the “frequency doubled double pulse 
Nd:YAG” (FREDDY), including a KTP crystal embedded 
into a Nd:YAG laser.28 A number of lasers have been trialed 
for laser lithotripsy, of which, the Ho:YAG has become 
one of the most commonly used.29 The mechanism of 
laser stone fragmentation is through photothermal effect, 
which depends on contact of the laser tip with the stone.30 
A major benefit is least retropulsion effect in the course 
of surgery.31
In a prospective randomized controlled trial, in 2008, 
Maghsoudi et al studied 79 subjects with 82 ureteral 
calculi, comparing Ho:YAG laser vs pneumatic lithotripsy. 
The retropulsion effect occurred in 1 case from the laser 
group (2.4%) vs 3 cases of pneumatic lithotripsy (P = 0.6). 
Stone free rate (SFR) was higher in Ho:YAG laser group 
vs pneumatic lithotripsy (37 cases (90.2%) vs 30 cases 
(73.20%) (P = 0.46).32
In another randomized controlled trial, in 2010, Basiri 
et al studied 100 children with distal ureteral stone, 
compared transurethral  lithotripsy with shock wave 
lithotripsy (SWL) and holmium laser to evaluate the 
superior modality. Both were suitable modalities for 
removal of distal ureteral stone at that age range. SFR 
was remarkably higher in the transurethral lithotripsy 
group than in the SWL group (respectively P < 0.004 and 
P < 0.001) and need to repeat the treatment in SWL was 
higher than transurethral  lithotripsy (TUL) (P < 0.004).33
In a case report, Hosseini et al in 2011 presented a patient 
with a solid stony mass which was in the perineum after 
Two-Stage Urethroplasty. They concluded that Ho: YAG 
laser is a minimally invasive modality which is suitable for 
management of urethral stones in such cases.34
Amjadi et al in 2011 published a report of transurethral 
lithotripsy of ureteral stone with holmium in 41 children 
≤12 years. They demonstrated that complications 
after ureteroscopic laser lithotripsy are rare. With the 
application of Ho: YAG laser with flexible fibers, the 
chance of treatment increases and SFR was 89.35%.35
In another study, Razzaghi et al compared pneumatic and 
holmium laser on 112 patients in 2011.  They reported 
that laser lithotripsy is an advanced method for treatment 
of ureteral stones larger than 1 cm. The success rate in the 
Ho: YAG laser group was higher than in the pneumatic 
group (P = 0.003). Operation time and hospitalization 
time were decreased,  and there were no significant 
complications.36
In a case report published by Razzaghi et al, the use of 
Ho: YAG laser ureteroscopic lithotripsy in a patient with 
ectopic malrotated kidney was discussed, and Ho: YAG 
laser lithotripsy was effective and safe in this patient.37
In a randomized clinical trial done in 2013 by Razzaghi et 
al on 112 subjects, pneumatic lithotripters and holmium 
laser were compared in the treatment of ureteral stones. 
Laser lithotripsy was safer and a more effective procedure 
for the treatment of upper ureteral calculi with a diameter 
of 1 to 2 cm, due to its higher SFR. SFR in the laser group 
was higher than in the pneumatic group (P = 0.001).38
Javanmard et al in 2015 compared flexible ureteroscopy 
versus extracorporeal SWL (ESWL) in the treatment of 
renal stones of 1-2 cm in 58 obese patients. Retrograde 
intrarenal surgery (RIRS) offers a good outcome for 
treatment of these patients. The operation time, SFR and 
rate of complication were higher in RIRS group vs ESWL 
group (P = 0.061, P = 0.019 and P = 0.211, respectively).39
In another randomized clinical trial by Javanmard et al 
on 46 patients with renal stones in 2016, they compared 
outcomes of RIRS with ESWL for stones ≤2 cm. The 
RIRS procedure was associated with less pain and higher 
success and was a safe option for renal stones ≤2 cm. 
Inferior ca lyx stones resolved significantly in RIRS vs 
SWL (100% vs. 40%, P = 0.02).40
Mehrabi et al studied 59 patients for comparison of laser 
lithotripsy by semi-rigid ureteroscope vs ESWL. SFR in 
semi-rigid ureteroscope vs ESWL was 85% and 87.5% 
respectively (P > 0.05). They concluded that transurethral 
lithotripsy by semi-rigid ureteroscope can be used as an 
alternative modality in management of upper ureteral 
calculi.41
In a prospective study by Karami et al, 48 patients were 
assessed for the safety and efficacy of transurethral 
cystolithotripsy of large bladder stones by holmium 
laser in the outpatient setting. SFR was 98.5%. Major 
complications and recurrence of bladder stone were not 
seen.42
Another study was about the safety and efficacy of laser 
lithotripsy in pregnancy reported by Abedi et al. In this 
retrospective study, 15 pregnant women with ureteral 
stones treated with semi-rigid ureteroscope and holmium 
laser were included. They concluded that laser lithotripsy 
is a safe method in pregnant patients with ureteral stone 
where conservative treatment failed.43
Lower and Upper Urinary Tract Strictures
The description of an argon laser for treatment of urethral 
strictures goes back to 1978. Using the laser instead 
of a cold knife,44 looked effective, however follow up 
demonstrated a recurrence rate of up to 70.1% in a mean 
time of 15.2 months. Ho:YAG, Nd:YAG and KTP lasers 
have also been investigated.45 Recently, the Thu:YAG 
laser was investigated in this setting. Penetration depth 
of this laser which is only 0.3 mm leads to very limited 
injury to adjacent tissue.46 The Ho:YAG laser  can treat 
ureteropelvic junction obstruction (UPJO)  with the 
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endopyelotomy method, similar outcomes to those with 
the ‘hot-wire balloon’ were achieved.30 The Ho:YAG laser 
is also effective in the minimally invasive management 
of ureterointestinal anastomotic strictures after urinary 
diversion as well as ureterovesical strictures at anastomosis 
sites after renal transplant.47
Razzaghi reported a 19-year-old male patient with 
urethral stricture that underwent internal urethrotomy 
with Ho-YAG laser. Total of fibrotic tissues was cut and 
a 18Fr siliconized Foley catheter passed for the patient. 
According to this study, urethrotomy with Ho-YAG 
laser is less invasive and safe. It is effective alternative 
for patients taking anti-coagulant drugs and are prone to 
have urethral bleeding.48
In a study, Razzaghi et al presented a 47-year-old woman 
who had undergone previous open pyeloplasty. Just below 
the right UPJ, a full-thickness lateral incision was done 
with Ho:YAG laser and carried through the stenotic 
segment up to the renal pelvis. Three months after surgery, 
half-time of excretion of radioisotope from right kidney in 
diuretic renogram was 13 minutes. Complications such as 
bleeding, pain, leakage and infection were not reported.49
In a prospective study, Sharifiaghdas et al incised 
bladder neck with 2-micron CW laser in a woman with 
bladder outlet stricture. After treatment, improvement of 
International Prostate Symptom Score (IPSS) (P = 0.005), 
quality of life (P = 0.005) and reduction of PVR (P = 0.003) 
were seen.50
Prostate Adenocarcinoma 
The probability of focal laser ablation of localized prostate 
cancer has recently been studied. The diode laser or 
Nd:YAG laser can be used for this purpose. A recent 
advance is the ability of real-time monitoring of lesion 
created by the laser with magnetic resonance imaging.51
In a study in 2014, Javanmard et al investigated 36 patients 
to evaluate laser ablation of prostate by diode laser 
prostate for treating bladder outlet obstruction symptoms 
due to prostate cancer. After surgery, the results of the 
comparison between diode laser ablation and channel 
TUR of prostate showed improving IPSS, PVR and Qmax 
in both groups. Mean IPSS was 11.1 ± 4.1 in TURP group 
vs 11.7 ± 3.6 in laser group (P = 0.64). Mean PVR was 18.4 
± 3.5 mL in TURP group vs 17.7 ± 6.3 mL in laser group 
(P = 0.68). Mean Qmax in TURP vs laser groups was 20.1 
± 4.5 mL/s vs 19.4 ± 2.6 mL/s, respectively (P = 0.57).52 
Seminiferous Epithelium
In a basic study, Fakhataha  et al in 2003 investigated low 
power gallium-aluminium-arsenide (830 nm) laser to 
determine the qualitative and ultrastructural changes of 
the seminiferous epithelium after laser radiation. Laser 
radiation can lead to double contradictory effects on 
spermatogenesis. Low doses of laser lead to improvement 
in the count of the germ cells with normal ultrastructural 
features, while the doses higher than biostimulative 
threshold can lead to defect in spermatogenesis.53
Conclusion
We reviewed all the available literature on laser application 
in Iran. Although laser applications in medical science 
and especially urology are at an increasing pace, we 
conclude that usage of this technology has not yet found 
its position in Iran, especially in the field of urology. The 
main causes for this are the difficult accessibility and 
disturb of laser devices and its accessories, as well as the 
lack of adequate knowledge of the medical community 
about this modality.  As mentioned in the above review, 
the published studies have mostly been from a university 
center that has been the founder and practitioner of laser 
applications in medical sciences and the field of urology, 
which indicates a weakness in extending the use of this 
technology in universities.
On the basis of the literature review in this paper future 
work will involve:
• Put training of laser foundations and its applications 
in medical sciences in specialized curriculum training
• Holding courses and workshops
• Organizing congresses and live surgery/performances 
or video
• Conducting laser medical rehearsal courses
• Require learning of some operation, such as ureteral 
stone or prostate laser in Urology educational 
curriculum. 
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